Digest Network Come funziona
Network
/
Società
Jo
Non verificato

Johnson & Johnson

Di cosa scriviamo

BiotecnologiaFarmaceuticaSaluteSanitàWeb e Social Network

112 comunicati stampa

Guarda tutti i comunicati
01/11/2026
Eventi
Industria
Salute
Attrezzature medico-sanitarie
Medicina - Varie
Scienza
Cardiologia
Biotecnologia
Data Show Positive Survival and Patient Outcomes with Best-Practice Impella Support in HRPCI, in Contrast to CHIP-BCIS3 Study Results
Fonte
Johnson & Johnson
Emittente
Business Wire
1.00
0
27/10/2026
Farmaceutica
Ottica
Oncologia
Attrezzature medico-sanitarie
HIV, AIDS e malattie autoimmuni
Biotecnologia
Medicina - Varie
Cardiologia
Salute
Web e Social Network
Eventi
Johnson & Johnson to Host Enterprise Business Review
Fonte
Johnson & Johnson
Emittente
Business Wire
1.00
0
22/10/2026
Johnson & Johnson Reports First Real-World VARIPULSE Pro Platform Data and 12-Month OMNYPULSE Platform Outcomes for Atrial Fibrillation Treatment at APHRS 2026
Fonte
Johnson & Johnson
Emittente
Business Wire
1.00
0
20/10/2026
Johnson & Johnson Launches Next-Generation Shockwave™ C2 Aero Fly Coronary IVL Catheter, Cutting IVL Treatment Time in Half
Fonte
Johnson & Johnson
Emittente
Business Wire
1.00
0
20/10/2026
Tecnica
Medicina - Varie
Biotecnologia
Sanità
Farmaceutica
Salute
Information Technology
Eventi
Web e Social Network
Johnson & Johnson to Showcase the Future of Surgical Intelligence at Abu Dhabi Future Health Summit 2026
Fonte
Johnson & Johnson
Emittente
Business Wire
1.00
0
13/10/2026
Oncologia
Salute
Sanità
Medicina - Varie
Farmaceutica
Biotecnologia
Titoli e azioni
Johnson & Johnson Announces Quarterly Dividend for Fourth Quarter 2026
Fonte
Johnson & Johnson
Emittente
Business Wire
1.00
0
13/10/2026
Biotecnologia
Farmaceutica
Salute
Medicina - Varie
Web e Social Network
Telefonia e Varie
Mercato azionario
Johnson & Johnson reports Q3 2026 results, raises 2026 guidance
Fonte
Johnson & Johnson
Emittente
Business Wire
1.00
0
01/10/2026
New Global Survey by Johnson & Johnson Finds Most Women Don’t Connect Eye Health Changes with Menopause
Fonte
Johnson & Johnson
Emittente
Business Wire
1.00
0
10/09/2026
Industria
Attrezzature medico-sanitarie
Pubblico Esercizio/Vendita al dettaglio
Salute
Sanità
Ottica
Johnson & Johnson Receives CE Marking for ACUVUE OASYS MAX Reusable Contact Lenses
Fonte
Johnson & Johnson
Emittente
Business Wire
1.00
0
02/09/2026
Eventi
Web e Social Network
Biotecnologia
Sanità
Farmaceutica
Salute
Johnson & Johnson to Participate in the Deutsche Bank 2026 Healthcare Summit
Fonte
Johnson & Johnson
Emittente
Business Wire
1.00
0

Recapiti

Social Media

Seguaci
0
Compatibilità
0